[Hemodialysis with a high permeability membrane in the treatment of encephalopathy of fulminant hepatitis].
Twenty-nine patients with fulminant hepatic failure and at least grade III encephalopathy were treated by haemodialysis with a polyacrylonitrile membrane. Aetiology was toxic in five patients, viral in eleven (2 due to hepatitis A virus and 9 presumed due to hepatitis B virus), not found in thirteen. Each patient was dialysed for 4 h every day, until he regained consciousness or died. Conscious level was improved after dialysis in 59% of patients. Thirteen patients survived (44.8%) :4 toxic hepatitis, 4 viral hepatitis B, 1 viral hepatitis A, 4 hepatitis of unknown aetiology. A comparison of plasma concentrations of amino acids measured by chromatography before and after 113 periods of haemodialysis in 23 patients showed significant decrease in aromatic amino acids (p less than 0.001), a significant increase in two branched-chain amino acids :leucine (p less than 0.001) and isoleucine (p less than 0.001), and a significant increase in Fischer's ratio (p less than 0.001). In survivors, factor V concentration on admission and Fischer's ratio on admission were significantly higher than in those who died (p less than 0.02 for both), but there was no significant difference in the difference between Fischer's ratio before and after haemodialysis. Haemodialysis was well tolerated, except for short periods of hypotension and a small but significant fall in platelet counts. Improvement in cerebral function during haemodialysis was previously demonstrated by various authors, but the effect on survival rate remained controversial. The survival rate obtained in this controlled study is clearly higher than those obtained by conservative management alone.
Gardère
J J
JJ
Service de Réanimation Médicale A et B, Hôpital Pellegrin-Tripode, Bordeaux.
Castaing
Y
Y
Gbikpi-Bénissan
G
G
D000180:Acrylic Resins; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000097:blood; D005165:Factor V / Q000032:analysis; D006501:Hepatic Encephalopathy / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008567:Membranes, Artificial; D008875:Middle Aged; D006435:Renal Dialysis
D000180:Acrylic Resins; D000596:Amino Acids; D008567:Membranes, Artificial; C010504:polyacrylonitrile; D005165:Factor V
Hémodialyse sur membrane à haute perméabilité dans le traitement de l'encéphalopathie des hépatites fulminantes.